Home Data Calendar Blog

FGEN

Tables

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31
Common Stock Value 0.940.940.930.930.930.930.920.910.910.900.890.880.870.870.860.850.850.840.830.820.820.710.640.640.630.630.620.620.610.600.590.59NANANA
Weighted Average Number Of Diluted Shares Outstanding 93.7793.47NANA92.8192.28NANA93.6889.45NANA87.0191.73NANA84.5183.75NANANA69.64NANANA69.02NANANA68.75NANANA37.11NA
Weighted Average Number Of Shares Outstanding Basic 93.7793.47NANA92.6492.28NANA90.5689.45NANA87.0186.44NANA84.5183.75NANANA69.64NANANA62.58NANANA59.80NANANA13.35NA
Weighted Average Number Of Share Outstanding Basic And Diluted NANA93.04NANA92.2891.69NANA89.4588.22NANANA85.70NA84.5183.7582.86NA75.8969.6464.04NA62.86NA62.18NA60.77NA59.20NA13.50NA13.21
Earnings Per Share Basic -0.98-0.78NANA0.54-1.45NANA0.36-0.95NANA-0.571.34NANA-0.50-0.28NANANA-0.48NANANA0.39NANANA0.95NANANA1.36NA
Earnings Per Share Diluted -0.98-0.78NANA0.54-1.45NANA0.35-0.95NANA-0.571.26NANA-0.50-0.28NANANA-0.48NANANA0.35NANANA0.83NANANA0.58NA
Earnings Per Share Basic And Diluted NANA-0.68NANA-1.45-0.78NANA-0.95-0.89NANANA-0.530.25-0.50-0.28-0.50-0.24-0.50-0.46-0.52-0.54-0.38NA-0.45-0.85-0.74NA-0.78-2.50-2.93NA-1.23

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31
Revenue From Contract With Customer Excluding Assessed Tax 15.7329.8160.8316.54155.9724.3638.4365.0044.0342.8924.407.9733.17191.5723.86108.0629.0343.9531.9330.7440.5530.2726.8935.5230.1089.2828.2824.4419.54120.5516.3016.1113.6689.9617.88
Revenues 15.7329.8160.8316.54155.9724.3638.4365.0044.0342.8924.407.9733.17191.5723.86108.0629.0343.9531.9342.5127.2729.0026.8931.9130.1089.2828.2824.4419.54120.5516.3016.1113.6689.9617.88
Cost Of Revenue 4.316.814.243.123.273.083.402.622.21NANANANANANANANANANANANANANANANANANANANANANANANANANA
Costs And Expenses 109.39108.03123.82151.78105.00158.20108.86123.0011.70NANANANANANANANANANANANANANANANANANANANANANANANANANA
Research And Development Expense 75.1870.9689.02113.9275.88122.5774.6878.1358.4861.4154.9056.8049.9652.0150.5070.2856.4452.1456.9752.4750.3446.9846.7350.6140.5652.3943.6559.9252.0751.5550.5451.2640.6233.2725.65
General And Administrative Expense 29.90NANANA25.85NANANANANANANANANANA17.8515.3615.0515.5513.8512.9513.4311.5312.5911.6510.3811.4212.9611.249.6810.4812.8210.147.526.43
Selling General And Administrative Expense 29.9030.2630.5634.7425.8532.5530.7842.25-48.9863.5349.6050.7135.8226.7422.2117.8515.3615.0515.55NANANANANANANANANANANANANANANANA
Operating Income Loss -93.66-78.22-62.99-135.2450.97-133.84-70.43-58.0032.33-85.14-81.07-100.44-52.85112.82-48.8419.92-42.77-23.24-40.60-23.81-36.02-31.41-31.37-31.28-22.1026.51-26.79-48.45-43.7759.31-44.72-47.97-37.0949.17-14.21
Interest Expense 0.080.140.100.110.110.350.500.540.580.650.630.670.700.740.772.732.742.752.771.802.772.762.382.752.762.442.782.752.762.762.762.932.722.732.73
Interest Income Expense Nonoperating Net 1.715.06-0.420.93-1.41-0.72-0.95-0.470.89-0.012.532.383.493.393.411.040.34-0.10-0.701.84-1.66-1.73-1.73-2.53-1.89-2.31-1.36-2.64-1.30-2.06-1.92NANANANA
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments -91.94-73.17-63.41-134.3149.56-134.55-71.38-58.2733.23NANANANANANANANANANANANANANANANANANANANA57.26-46.64NANA46.83-16.24
Income Tax Expense Benefit 0.110.020.110.110.11-0.000.130.170.210.17-0.190.070.080.20-0.030.010.120.070.100.150.060.050.060.190.16-0.11-0.300.280.030.20-0.270.000.000.000.00
Profit Loss -91.65-72.62-63.20-134.0849.80-133.99-71.75-58.6333.00-85.31-78.35-98.12-49.44116.00-45.4120.95-42.56-23.42-41.40-33.89-24.46NANANANANANANANANANANANANANA
Other Comprehensive Income Loss Net Of Tax -0.42-0.42-2.34-0.010.410.06-0.12-0.24-2.69-2.741.93-0.520.240.470.730.290.041.01-0.58-0.19-0.22-0.37-0.060.37-0.310.68-0.05-0.04-0.990.122.410.030.96-0.10-0.53
Net Income Loss -91.65-72.62-63.20-134.0849.80-133.99-71.75-58.6333.00-85.31-78.35-98.12-49.44116.00-45.4120.95-42.56-23.42-41.40-22.12-37.74-33.18-33.16-34.00-24.1524.32-27.84-51.37-45.1057.05-46.37-50.56-39.5346.83-16.24
Comprehensive Income Net Of Tax -92.07-73.05-65.55-134.0850.21-133.93-71.88-58.8830.31-88.06-76.42-98.65-49.20116.48-44.6821.24-42.52-22.41-41.97-22.31-37.96-33.55-33.22-33.63-24.4625.00-27.89-51.41-46.0957.17-43.96-50.53-38.5846.74-16.77

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31
Assets 608.84686.79745.93773.82850.51808.62787.30826.84812.01807.68824.38857.40893.96915.07812.40880.60855.64869.92867.61898.65894.89542.64441.76469.55486.21499.13442.54470.57499.25541.39435.54483.53NANANA
Liabilities 562.56563.04567.92544.71505.45528.77397.03385.39341.08392.54346.75321.99280.25266.76303.90352.13365.06355.12348.82316.20304.12293.27290.78294.44288.60286.75266.31273.75262.69268.51231.65242.85NANANA
Liabilities And Stockholders Equity 608.84686.79745.93773.82850.51808.62787.30826.84812.01807.68824.38857.40893.96915.07812.40880.60855.64869.92867.61898.65894.89542.64441.76469.55486.21499.13442.54470.57499.25541.39435.54483.53NANANA
Stockholders Equity 26.31103.78158.05209.15325.79260.58371.00422.18451.66395.87458.36516.13594.45629.03489.22509.20471.31495.53499.52563.18571.50230.10131.70155.84178.34193.11156.95177.55217.28253.62184.62221.41NANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31
Assets Current 474.22520.64524.41474.06573.40564.47621.69755.11737.48727.17736.40702.49786.48805.79579.00690.01678.78720.08717.16748.97741.46371.34256.58266.52253.46252.31184.00200.56232.57263.58155.40198.24NANANA
Cash 104.51128.15165.44111.4290.90130.03100.7388.0580.55198.7149.4140.7290.7740.7872.2838.7871.5963.5269.56103.72104.88205.0286.6879.2492.6277.0996.2075.6995.49108.89119.11151.65NANANA
Cash And Cash Equivalents At Carrying Value 155.96167.76185.90171.22274.53353.36433.51678.39532.47429.27121.56126.27196.5974.5981.6789.26566.72643.80659.01673.66651.37290.28170.60173.78198.28190.41140.96153.32208.65236.54128.37165.46153.89182.6672.95
Short Term Investments 252.56270.38242.18233.97211.88153.85110.728.14155.40256.32413.87407.49432.04586.17483.73532.1486.01NANA62.06NANANANANANANANANANANANANANANA
Accounts Receivable Net Current 15.3333.5743.8817.4035.9924.2740.5441.8826.2526.5258.5428.4519.236.456.0263.6823.1930.199.978.458.638.937.2510.457.6918.095.9415.407.3712.186.9613.45NANANA
Inventory Net 39.9540.9043.0731.0229.3224.5320.7616.5311.808.588.416.894.911.98NA0.004.91NANANANANANANANANANANANANANANANANANA
Inventory Finished Goods 3.515.197.878.157.837.807.796.115.034.445.004.30NANANANANANANANANANANANANANANANANANANANANANANA
Prepaid Expense And Other Assets Current 10.438.049.3920.4521.698.4616.1610.1611.566.48134.03133.39133.72136.607.584.932.8718.003.424.802.863.015.912.893.963.714.653.993.682.735.754.97NANANA
Available For Sale Securities Debt Securities 270.34316.30335.67401.76NANANA8.39NANANANANANANANANANANANANANANANANANANANANANANANANANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31
Property Plant And Equipment Net 22.2924.5026.8828.2829.0530.6730.9333.6536.1536.9840.0642.7443.2144.8745.83127.20127.91128.83129.88129.48126.64122.59122.82123.66124.77126.26127.61129.02129.61130.45131.66132.17NANANA
Other Assets Noncurrent 4.944.506.935.925.114.629.133.434.036.868.609.377.074.814.193.423.175.244.884.523.813.282.982.151.991.761.662.021.841.801.711.60NANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31
Liabilities Current 251.99240.34255.37225.50209.32232.76167.05163.19118.3577.5766.10102.7587.2982.8193.9289.03100.4390.5683.3477.2668.5059.7760.1165.1261.7466.4458.3067.1858.9963.5053.9662.75NANANA
Accounts Payable Current 19.3229.3636.3526.1023.8748.9924.0624.797.555.012.876.094.054.063.779.1410.133.223.555.516.413.262.956.222.043.471.546.524.233.922.434.55NANANA
Other Accrued Liabilities Current 4.706.995.494.895.755.038.938.099.347.715.074.545.226.075.435.549.638.767.556.4610.337.417.645.886.974.564.174.764.143.243.505.56NANANA
Accrued Liabilities Current 213.81193.10203.30172.59151.35147.80119.78119.5290.5750.4642.3183.8270.8366.5566.2866.1252.6049.4962.8663.7854.1248.5349.1850.9151.7547.9444.0447.9341.7746.2442.4748.98NANANA
Contract With Customer Liability Current 7.366.904.7415.8623.2625.2310.726.557.919.818.530.490.260.1412.1013.7737.7037.84NA16.67NANANANANANANANANANANANANANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31
Minority Interest 19.9719.9719.9719.9719.2719.2719.2719.2719.2719.2719.2719.2719.2719.2719.2719.2719.2719.2719.2719.2719.2719.2719.2719.2719.2719.2719.2719.2719.2719.2719.2719.27NANANA
Other Liabilities Noncurrent 14.3017.8324.3326.0224.3230.6638.3439.6437.64127.2489.1264.2736.0419.069.989.9910.299.328.568.056.696.255.846.194.764.995.244.610.750.700.700.70NANANA
Operating Lease Liability Noncurrent 81.0983.0885.9588.7891.4894.203.350.850.470.570.680.94NANANA0.00NANANANANANANANANANANANANANANANANANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31
Stockholders Equity 26.31103.78158.05209.15325.79260.58371.00422.18451.66395.87458.36516.13594.45629.03489.22509.20471.31495.53499.52563.18571.50230.10131.70155.84178.34193.11156.95177.55217.28253.62184.62221.41NANANA
Stockholders Equity Including Portion Attributable To Noncontrolling Interest 46.27123.75178.01229.11345.06279.85390.27441.45470.93415.14477.63535.41613.72648.30508.49528.47490.58514.80518.79582.45590.77249.37150.97175.11197.62212.38176.22196.82236.56272.89203.89240.68NANANA
Common Stock Value 0.940.940.930.930.930.930.920.910.910.900.890.880.870.870.860.850.850.840.830.820.820.710.640.640.630.630.620.620.610.600.590.59NANANA
Additional Paid In Capital 1524.231509.641490.861476.411458.981443.971420.471399.771370.381344.911319.351300.721280.401265.781242.461226.451209.81NANA1160.09NANANANANANANA586.65574.98565.23553.41546.25NANANA
Retained Earnings Accumulated Deficit -1491.51-1399.86-1327.24-1264.03-1129.96-1179.75-1045.77-974.01-915.38-948.38-863.07-784.72-686.60-637.16-753.16-715.83-736.78-694.22-670.80-595.95-573.82-536.09-502.90-469.74-435.74-411.59-435.90-408.06-356.69-311.60-368.65-322.28NANANA
Accumulated Other Comprehensive Income Loss Net Of Tax -7.35-6.93-6.50-4.16-4.16-4.57-4.62-4.50-4.26-1.561.18-0.75-0.22-0.46-0.94-2.28-2.57-2.61-3.62-1.79-1.61-1.39-1.02-0.96-1.33-1.02-1.70-1.65-1.61-0.62-0.74-3.15NANANA
Minority Interest 19.9719.9719.9719.9719.2719.2719.2719.2719.2719.2719.2719.2719.2719.2719.2719.2719.2719.2719.2719.2719.2719.2719.2719.2719.2719.2719.2719.2719.2719.2719.2719.27NANANA
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 15.5916.6617.1517.0715.7019.0019.3820.2717.8917.6416.9217.4014.7917.6416.4313.7114.3213.2310.88NANANANANANANANANANANANANANANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31
Net Cash Provided By Used In Operating Activities -51.88-33.06-8.48-54.9644.26-26.54-44.98-7.23-1.35149.66-59.49-45.05-27.48-28.6522.48-17.468.25-34.96-31.96-1.19-18.43NANANANANANANANANANANANANANA
Net Cash Provided By Used In Investing Activities 44.7817.3025.93-50.57-122.15-57.53-196.72143.7798.86153.8556.01-25.03152.7718.77-26.49-462.86-89.2014.6415.3020.009.54NANANANANANANANANANANANANANA
Net Cash Provided By Used In Financing Activities -1.092.09-2.89-0.03-0.832.38-2.085.664.224.65-1.19-0.28-3.242.75-3.532.823.925.092.043.41370.02NANANANANANANANANANANANANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31
Net Cash Provided By Used In Operating Activities -51.88-33.06-8.48-54.9644.26-26.54-44.98-7.23-1.35149.66-59.49-45.05-27.48-28.6522.48-17.468.25-34.96-31.96-1.19-18.43NANANANANANANANANANANANANANA
Net Income Loss -91.65-72.62-63.20-134.0849.80-133.99-71.75-58.6333.00-85.31-78.35-98.12-49.44116.00-45.4120.95-42.56-23.42-41.40-22.12-37.74-33.18-33.16-34.00-24.1524.32-27.84-51.37-45.1057.05-46.37-50.56-39.5346.83-16.24
Profit Loss -91.65-72.62-63.20-134.0849.80-133.99-71.75-58.6333.00-85.31-78.35-98.12-49.44116.00-45.4120.95-42.56-23.42-41.40-33.89-24.46NANANANANANANANANANANANANANA
Increase Decrease In Accounts Receivable -17.18-10.2826.48-19.0511.74-16.53-1.3414.49-0.62-31.9930.099.2312.770.43-57.6640.50-7.0020.211.52-0.18-0.301.69-3.202.76-10.4012.15-9.478.03-4.815.22-6.49-7.975.26-4.983.65
Increase Decrease In Inventories 0.29-1.1412.001.504.803.574.293.973.190.491.521.982.931.980.000.000.00NANANANANANANANANANANANANANANANANANA
Increase Decrease In Accounts Payable -9.31-6.0110.211.92-0.10-0.34-0.6716.292.502.16-3.222.03-0.010.29-5.37-0.996.91-0.33-1.96-0.903.150.31-3.274.18-1.441.93-4.982.290.321.48-2.121.661.640.110.08
Share Based Compensation 15.5716.6617.1517.0715.7019.0019.3820.2717.8917.6416.9217.4014.7917.6416.4313.7114.3213.2310.889.939.639.578.417.888.518.407.347.456.846.946.458.968.270.670.80

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31
Net Cash Provided By Used In Investing Activities 44.7817.3025.93-50.57-122.15-57.53-196.72143.7798.86153.8556.01-25.03152.7718.77-26.49-462.86-89.2014.6415.3020.009.54NANANANANANANANANANANANANANA
Payments To Acquire Property Plant And Equipment 0.860.911.641.401.571.700.522.390.420.730.461.751.811.720.483.171.151.871.843.513.380.980.640.150.090.120.900.310.680.540.452.581.591.622.33

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31
Net Cash Provided By Used In Financing Activities -1.092.09-2.89-0.03-0.832.38-2.085.664.224.65-1.19-0.28-3.242.75-3.532.823.925.092.043.41370.02NANANANANANANANANANANANANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31
Revenues 15.7329.8160.8316.54155.9724.3638.4365.0044.0342.8924.407.9733.17191.5723.86108.0629.0343.9531.9342.5127.2729.0026.8931.9130.1089.2828.2824.4419.54120.5516.3016.1113.6689.9617.88
Revenue From Contract With Customer Excluding Assessed Tax 15.7329.8160.8316.54155.9724.3638.4365.0044.0342.8924.407.9733.17191.5723.86108.0629.0343.9531.9330.7440.5530.2726.8935.5230.1089.2828.2824.4419.54120.5516.3016.1113.6689.9617.88
Gross Accounts Receivable, Rebates And Discounts 0.000.100.600.300.00NANA-9.304.20NANANANANANANANANANANANANANANANANANANANANANANANANANA
Development And Other Revenue 2.455.4611.769.9526.1019.6414.5921.5320.6618.9619.4528.6120.6640.9823.8635.3329.0329.6331.9330.7430.6230.27NANANANANANANANANANANANANA
Drug Product Revenue -4.081.097.591.130.00-8.658.48-0.020.698.24NANANA0.00NANANANANANANANANANANANANANANANANANANANANA
License 0.000.0022.590.00116.43NANANANA0.000.0014.5711.94150.580.007.950.0014.320.000.009.93NANANANANANANANANANANANANANA
Product 17.3623.2618.885.4613.4413.3715.3629.1722.6815.694.96-35.200.580.000.0064.780.00NANANANANANANANANANANANANANANANANANA
Development And Other Revenue, License Agreement With Eluminex 0.46NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
License, License Agreement With Eluminex NA0.280.760.008.00NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Development And Other Revenue,, Astellas Collaboration Agreement 1.371.755.151.5414.062.553.534.134.654.604.573.713.0016.854.614.124.665.004.724.554.80NANANANANANANANANANANANANANA
Development And Other Revenue,, Astellas Collaboration Agreement 0.040.080.030.000.070.100.080.810.090.160.160.070.540.370.250.340.471.140.450.460.520.32NANANANANANANANANANANANANA
Development And Other Revenue, United States Rest Of World And China, Astra Zeneca Agreements 0.583.355.828.4111.9716.9910.9817.9815.2213.7514.5624.7617.1123.7619.0030.8723.8923.4826.72NANANANANANANANANANANANANANANANA
License,, Astellas Collaboration Agreement 0.000.0022.590.00108.43NANANANA0.000.000.000.00117.470.000.000.000.000.000.000.00NANANANANANANANANANANANANANA
Product,, Astra Zeneca Agreements NA19.7016.203.1010.3011.8010.40NANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Product,, Direct Sales NA3.502.702.403.101.605.00NANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Product, Direct Sales 2.443.522.662.393.111.614.9629.1722.6815.694.96NANANANANANANANANANANANANANANANANANANANANANANANA
Product, Sales To Falikang 14.9119.7416.223.0710.3311.7610.41NANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Product, Direct Sales, Discounts And Rebates -0.17-0.01-0.17NA-0.13-0.62-0.56NA-5.21-4.09-0.42NANANANANANANANANANANANANANANANANANANANANANANANA
Product, Direct Sales, Sales Returns And Allowances 0.000.000.00-0.00-0.00-0.000.09-0.04-0.01-0.04NANANANANANANANANANANANANANANANANANANANANANANANANA
Product, Sales To Falikang, Increase In Deferred Revenue -4.62-1.52-2.35-9.13-8.76-5.38-3.93NANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Product, Sales To Falikang, Net Transfer Price 19.5318.2213.8812.2019.0917.1414.34NANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Product, Sales To Falikang, Profit Share -12.98-10.06-8.85-3.03-12.09-9.57-10.06NANANANANANANANANANANANANANANANANANANANANANANANANANANANA
, A P I Shipment, Drug Product Revenue NANA2.20NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
, Astellas Collaboration Agreement NA1.10NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
, Astellas Agreement, Drug Product Revenue 0.241.08NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
, Astellas Agreement, Drug Product Revenue 4.310.02NANA0.00-1.97NANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
, Astellas Collaboration Agreement, Drug Product Revenue NA0.007.600.002.10-2.004.00NANA8.20NANANANANANANANANANANANANANANANANANANANANANANANANA
, Drug Product Revenue NANA9.80NANANANANANA8.20NANANANANANANANANANANANANANANANANANANANANANANANANA
A P I Shipment, Drug Product Revenue -4.30NA2.200.000.002.004.00NANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Astellas Agreement, Bulk Drug Product 7.70-2.2045.50NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Astellas Agreement, Drug Product Revenue NANA7.591.130.00-1.974.030.00-3.968.24NANANANANANANANANANANANANANANANANANANANANANANANANA
Astra Zeneca Agreements, Bulk Drug Product 0.000.0011.20NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Deferred For Future Recognition 4.601.502.309.108.805.40NANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
Drug Product Revenue 4.081.097.591.130.00-8.658.48-0.020.698.24NANANANANANANANANANANANANANANANANANANANANANANANANA

Plots across concepts


IncomeStatement
Operating Income Loss
Expenses
Interest Expense
Balance Sheet
Stockholders Equity
Assets
Property Plant And Equipment Net
Current Assets
Prepaid Expense And Other Assets Current
NonCurrent Assets
Other Assets Noncurrent
Liabilities
Operating Lease Liability
Current Liabilities
Other Accrued Liabilities Current
Stockholders Equity
Retained Earnings Accumulated Deficit
CashFlow
Net Income Loss
NetCashProvidedByUsedInOperatingActivities
Net Income Loss
NetCashProvidedByUsedInInvestingActivities
Payments To Acquire Property Plant And Equipment
Shares
Weighted Average Number Of Share Outstanding Basic And Diluted
OperatingLeaseLiability
Operating Lease Liability Current
NonoperatingIncomeExpense
Interest Expense
InventoryNet
Inventory Finished Goods

Line plots across dimensions of each concept


TTM Greenblatt ROC
_
(None,)
T T M  Greenblatt  R O C_
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService
(None,)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService, us-gaap:StatementGeographical, us-gaap:TypeOfArrangement
('us-gaap:Product', 'CN', None)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service, us-gaap: Statement Geographical, us-gaap: Type Of Arrangement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService, us-gaap:TypeOfArrangement
('us-gaap:Product', None)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service, us-gaap: Type Of Arrangement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ValuationAllowancesAndReservesType
(None,)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Valuation Allowances And Reserves Type
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:StatementGeographical, us-gaap:TypeOfArrangement, us-gaap:ValuationAllowancesAndReservesType
('JP', None, 'fgen:DrugProductRevenue')
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Statement Geographical, us-gaap: Type Of Arrangement, us-gaap: Valuation Allowances And Reserves Type
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService, us-gaap:TypeOfArrangement, us-gaap:ValuationAllowancesAndReservesType
('us-gaap:Product', 'fgen:SalesToFalikang', None)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service, us-gaap: Type Of Arrangement, us-gaap: Valuation Allowances And Reserves Type
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService, us-gaap:TypeOfArrangement, us-gaap:ValuationAllowancesAndReservesType
('us-gaap:Product', 'fgen:DirectSales', None)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service, us-gaap: Type Of Arrangement, us-gaap: Valuation Allowances And Reserves Type
us-gaap:AvailableForSaleSecuritiesDebtSecurities
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency, us-gaap:InvestmentType
('us-gaap:FairValueInputsLevel2', 'us-gaap:FairValueMeasurementsRecurring', None)
Available For Sale Securities Debt Securitiesus-gaap: Fair Value By Fair Value Hierarchy Level, us-gaap: Fair Value By Measurement Frequency, us-gaap: Investment Type
us-gaap:AvailableForSaleSecuritiesDebtSecurities
us-gaap:FairValueByMeasurementFrequency, us-gaap:InvestmentType
('us-gaap:FairValueMeasurementsRecurring', None)
Available For Sale Securities Debt Securitiesus-gaap: Fair Value By Measurement Frequency, us-gaap: Investment Type
us-gaap:AvailableForSaleSecuritiesDebtSecurities
us-gaap:InvestmentType
(None,)
Available For Sale Securities Debt Securitiesus-gaap: Investment Type
us-gaap:AvailableForSaleSecuritiesDebtSecurities
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency, us-gaap:FinancialInstrument
('us-gaap:FairValueInputsLevel2', 'us-gaap:FairValueMeasurementsRecurring', None)
Available For Sale Securities Debt Securitiesus-gaap: Fair Value By Fair Value Hierarchy Level, us-gaap: Fair Value By Measurement Frequency, us-gaap: Financial Instrument
us-gaap:AvailableForSaleSecuritiesDebtSecurities
us-gaap:FairValueByMeasurementFrequency, us-gaap:FinancialInstrument
('us-gaap:FairValueMeasurementsRecurring', None)
Available For Sale Securities Debt Securitiesus-gaap: Fair Value By Measurement Frequency, us-gaap: Financial Instrument
us-gaap:AvailableForSaleSecuritiesDebtSecurities
us-gaap:FinancialInstrument
(None,)
Available For Sale Securities Debt Securitiesus-gaap: Financial Instrument
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
us-gaap:StatementEquityComponents
(None,)
Stockholders Equity Including Portion Attributable To Noncontrolling Interestus-gaap: Statement Equity Components
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService
(None,)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService, us-gaap:StatementGeographical, us-gaap:TypeOfArrangement
('us-gaap:Product', 'CN', None)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service, us-gaap: Statement Geographical, us-gaap: Type Of Arrangement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService, us-gaap:TypeOfArrangement
('us-gaap:Product', None)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service, us-gaap: Type Of Arrangement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ValuationAllowancesAndReservesType
(None,)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Valuation Allowances And Reserves Type
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:StatementGeographical, us-gaap:TypeOfArrangement, us-gaap:ValuationAllowancesAndReservesType
('JP', None, 'fgen:DrugProductRevenue')
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Statement Geographical, us-gaap: Type Of Arrangement, us-gaap: Valuation Allowances And Reserves Type
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService, us-gaap:TypeOfArrangement, us-gaap:ValuationAllowancesAndReservesType
('us-gaap:Product', 'fgen:SalesToFalikang', None)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service, us-gaap: Type Of Arrangement, us-gaap: Valuation Allowances And Reserves Type
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService, us-gaap:TypeOfArrangement, us-gaap:ValuationAllowancesAndReservesType
('us-gaap:Product', 'fgen:DirectSales', None)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service, us-gaap: Type Of Arrangement, us-gaap: Valuation Allowances And Reserves Type